Clinical Trial Update: Split-course SBRT for Borderline Resectable and Locally Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating split-course stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Neoplasms

Snippet

Sponsor: Fujian Medical University Union Hospital | Conditions: Pancreatic Neoplasms | Phase 2 | Status: UNKNOWN